Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Colitis, Ulcerative

• Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
• Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
• A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
• Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
• A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
• Alpha Lipoic Acid in Ulcerative Colitis
• A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
• A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants
• A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC)
• Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
• A Trial for Acute Severe Ulcerative Colitis
• CP101 for the Treatment of Ulcerative Colitis
• First in Human, Single Ascending Dose Study
• An Early Phase 2 Clinical Study of KSP-0243
• Combination of Diet and Oral Budesonide for Ulcerative Colitis
• Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
• Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
• Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
• Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)
• A Phase II Clinical Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
• Fenofibrate in Ulcerative Colitis
• A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis
• A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clin
• Role of Roflumilast in Ulcerative Colitis
• Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
• R-3750 in Patients With Mild to Moderate Ulcerative Colitis
• LMT503 First-in-human SAD, MAD, and FE Study
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis
• A Phase 2b Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
• Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
• Stem Cells for the Treatment of Pouchitis
• Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
• Metformin as Added on Therapy in Patients With Ulcerative Colitis
• Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis
• Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
• Atorvastatin in Patients With Ulcerative Colitis
• Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
• Metformin in Patients With Ulcerative Colitis Treated With Mesalamine
• A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
• ABTECT - Maintenance
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
• A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
• Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
• Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis
• A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission
• Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)
• A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis
• A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
• Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
• VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
• Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
• LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
• A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
• Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
• Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
• Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis
• Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
• The Nordic IBD Treatment Strategy Trial
• Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
• VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
• Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
• HCQ for Non Europeans With Mild to Severe UC
• Saffron and Ulcerative Colitis
• Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
• SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery
• A Long-term Extension Study of Ustekinumab in Pediatric Participants
• Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201
• An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
• Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis
• Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression
• Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
• Top Down Versus Step up in Pediatric Ulcerative Colitis
• A Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
• GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
• Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.
• Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)
• Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
• A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
• Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease
• MS-20 on Patients With Ulcerative Colitis(UC)
• A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis
• Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
• Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
• Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
• A Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants With Crohn's Disease or Ulcerative Colitis
• Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis
• Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
• GI Permeability Change in Response to Aquamin®
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
• Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis
• Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
• RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.
• Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
• A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis
• Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
• Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
• Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis
• A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)
• Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
• A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• Xeljanz and Healthy Diet
• PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
• Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis
• Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers
• A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis
• Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis
• Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
• Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects
• Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis
• Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis
• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
• Angiographic Delivery of AD-MSC for Ulcerative Colitis
• Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism
• Open-label Extension Study of Brazikumab in Ulcerative Colitis
• A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis
• Hydroxocobalamin Approach to Reduction of Calprotectin With Butyrate for Ulcerative Colitis Research
• A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
• SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101
• Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan
• A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis
• A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
• A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
• Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis
• Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis
• Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
• TUDCA as a Therapy for Ulcerative Colitis (UC)
• NIR FME of Labelled Vedolizumab to Elucidate the Mechanism of Action and Predicting Response in IBD Patients.
• Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis
• Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
• Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy
• Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol
• Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis
• Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
• Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
• Antimicrobial Therapy for Ulcerative Colitis (UC)
• Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis
• An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
• Low Sulfur Fecal Transplant for Ulcerative Colitis
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
• Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Patients With Ulcerative Colitis (UC)
• TITRATE (inducTIon for acuTe ulceRATivE Colitis)
• Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
• ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
• TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
• The Safety and Efficacy of TET Enema in the Treatment of UC
• To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
• Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
• Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis
• GB004 in Adult Subjects With Active Ulcerative Colitis
• Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
• Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
• Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
• Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)
• Fecal Microbiota Transplantation for Ulcerative Colitis
• Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
• Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
• Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
• Efficacy & Safety of TD-1473 in Ulcerative Colitis
• The Role of Secondary Bile Acids in Intestinal Inflammation
• Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
• A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
• EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
• A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis
• A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
• HMPL004-6599 Phase I Dose-escalating Study
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
• Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients
• 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
• Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
• A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
• Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
• First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
• A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease
• Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
• Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
• PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
• To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis
• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
• A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants
• Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
• Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
• A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
• Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
• An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
• Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
• Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
• Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
• Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
• The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
• High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
• Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
• Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
• A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy
• Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis
• Faecal Bacteriotherapy for Ulcerative Colitis
• TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
• Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis
• This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients
• ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
• A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
• Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
• Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
• A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
• GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )
• A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
• Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
• Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
• Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
• Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
• Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
• Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease
• Mercaptopurine Therapy in Ulcerative Colitis
• GSK2982772 Study in Subjects With Ulcerative Colitis
• Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
• Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis
• Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
• Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
• Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
• A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
• Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
• TD-1473 for Active Ulcerative Colitis (UC)
• Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC
• Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
• A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
• Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
• Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis
• Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
• An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
• Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
• A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)
• Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
• Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis
• Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis
• OTIS Vedolizumab Pregnancy Exposure Registry
• Entyvio (Vedolizumab) Long Term Safety Study
• Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
• An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
• Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
• Effectiveness of Cortiment® in Patients With Ulcerative Colitis
• Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
• Budesonide 9 mg Capsules in Active UC
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
• Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis
• Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
• Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
• A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
• Single-dose Linaclotide for Capsule Endoscopy Preparation
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
• Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
• "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
• Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
• Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
• Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET
• A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis
• Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
• Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
• An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
• Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
• Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
• Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis
• Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• TP0502-B-Pharmaco-Scintigraphic-Study
• TP0502-Pharmaco-Scintigraphic-Study and Amendment
• TP0501 - Pharmaco-Scintigraphic-Study
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
• Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)
• Curcumin in Pediatric Ulcerative Colitis
• Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis
• Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
• Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
• Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients
• Use of the Ulcerative Colitis Diet for Induction of Remission
• Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults
• Low Dose IL-2 for Ulcerative Colitis
• Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
• Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
• The NOR-SWITCH Study
• Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
• A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
• Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
• Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis
• Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
• Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
• Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
• Manipulating the Microbiome in IBD by Antibiotics and FMT
• Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002
• Early Serum Infliximab Levels in Severe Ulcerative Colitis.
• A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
• MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
• Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
• Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients
• Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
• TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
• HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
• A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
• Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
• Ulcerative Colitis and Vitamin D Supplementation
• A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
• Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
• Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
• A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
• Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
• Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis
• Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
• TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
• A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
• Photodynamic Therapy for Ulcerative Colitis
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis
• Efficacy of Gralise® for Chronic Pelvic Pain
• Adalimumab in the Treatment of Chronic Pouchitis
• Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
• A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis
• Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
• Vitamin D Treatment in Ulcerative Colitis
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
• Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
• Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
• Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
• Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
• A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
• Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
• Predicting Response to Standardized Pediatric Colitis Therapy
• Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)
• Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
• Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
• The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
• Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
• Role of Healthy Bacteria in Ulcerative Colitis
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
• Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
• A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
• A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
• Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis
• Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova
• Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis
• Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
• Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs
• Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients
• Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
• Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
• Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
• A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
• Oral OKT3 for the Treatment of Active Ulcerative Colitis
• Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
• Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
• A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis
• Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
• Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
• Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
• Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
• Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
• A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers
• Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
• Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
• (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets
• Study of Cimzia for the Treatment of Ulcerative Colitis
• Basiliximab Maintenance in Ulcerative Colitis
• Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
• A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
• Cannabis for Inflammatory Bowel Disease
• Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
• Cannabidiol for Inflammatory Bowel Disease
• Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis
• Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)
• Propionyl-L-Carnitine in Ulcerative Colitis
• Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
• Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
• A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
• Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)
• Trial of Chinese Prescription on Ulcerative Colitis
• Curcumin in Pediatric Inflammatory Bowel Disease
• A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
• A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
• (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
• An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
• Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
• A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
• Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
• Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
• Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
• Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
• Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis
• Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
• Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis
• Thalidomide in Pediatric Inflammatory Bowel Diseases.
• Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
• The Colitis Once Daily Asacol Study
• European Safety Registry in Ulcerative Colitis (P04808)
• A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
• (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
• (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
• Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
• Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
• Dose Escalation and Remission (DEAR)
• Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
• Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
• Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
• A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
• A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis
• A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
• Canadian Active & Maintenance Modified Pentasa Study
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
• Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
• Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
• Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476
• Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)
• Cost-effectiveness of TPMT Pharmacogenetics
• A Comparison of Once a Day Dose Compared to 2 Doses/Day
• Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
• Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
• An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
• Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis
• An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
• GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
• OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
• Basiliximab in Moderate to Severe Ulcerative Colitis
• Open-Label Adalimumab for Ulcerative Colitis Patients
• A Study of Abatacept in Patients With Active Ulcerative Colitis
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
• An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
• Antibiotics for the Treatment of Ulcerative Colitis
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
• Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients
• Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
• Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
• Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
• Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis
• Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
• Therapeutic Study of ONO-4819CD for Ulcerative Colitis
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
• Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
• A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
• Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
• Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
• Rituximab in Active Ulcerative Colitis
• Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
• Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis
• Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis
• A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
• Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
• Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
• A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
• Asacol Dosing Study for Active Ulcerative Colitis
• The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
• Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
• Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
• Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis
• CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
• A Trial of Rosiglitazone for Ulcerative Colitis
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
• ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.
• ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis
• Clotrimazole Enemas for Pouchitis in Children and Adults
• Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
• Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
• Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis
• Research Study in Patients With Severe Ulcerative Colitis
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis